0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bioanalytical Solutions Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-39B17671
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Bioanalytical Solutions Market Research Report 2024
BUY CHAPTERS

Global Bioanalytical Solutions Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-39B17671
Report
October 2025
Pages:173
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Bioanalytical Solutions Market

The global Bioanalytical Solutions market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
From a downstream perspective, Clinical accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Bioanalytical Solutions leading manufacturers including Eurofins Scientific, Charles River, LabCorp, Altasciences, Intertek, Celerion, ACM Global Laboratories, Q2 Solutions, WuXi AppTec, SGS, etc., dominate supply; the top five capture approximately % of global revenue, with Eurofins Scientific leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Bioanalytical Solutions market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Bioanalytical Solutions Market Report

Report Metric Details
Report Name Bioanalytical Solutions Market
Segment by Type
  • Small Molecule Bioanalysis
  • Large Molecule Bioanalysis
  • Biomarkers
  • Biologics and Vaccines
Segment by Application
  • Clinical
  • Non-clinical
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eurofins Scientific, Charles River, LabCorp, Altasciences, Intertek, Celerion, ACM Global Laboratories, Q2 Solutions, WuXi AppTec, SGS, Ardena, VTT, ICON, Simbec-Orion, Medpace, Frontage, Pharmaron, Veeda, GenScript, Sino Biological, Tigermed, Medicilon, Scinovo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Bioanalytical Solutions study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Bioanalytical Solutions Market report?

Ans: The main players in the Bioanalytical Solutions Market are Eurofins Scientific, Charles River, LabCorp, Altasciences, Intertek, Celerion, ACM Global Laboratories, Q2 Solutions, WuXi AppTec, SGS, Ardena, VTT, ICON, Simbec-Orion, Medpace, Frontage, Pharmaron, Veeda, GenScript, Sino Biological, Tigermed, Medicilon, Scinovo

What are the Application segmentation covered in the Bioanalytical Solutions Market report?

Ans: The Applications covered in the Bioanalytical Solutions Market report are Clinical, Non-clinical

What are the Type segmentation covered in the Bioanalytical Solutions Market report?

Ans: The Types covered in the Bioanalytical Solutions Market report are Small Molecule Bioanalysis, Large Molecule Bioanalysis, Biomarkers, Biologics and Vaccines

1 Study Coverage
1.1 Introduction to Bioanalytical Solutions: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Bioanalytical Solutions Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Small Molecule Bioanalysis
1.2.3 Large Molecule Bioanalysis
1.2.4 Biomarkers
1.2.5 Biologics and Vaccines
1.3 Market Segmentation by Application
1.3.1 Global Bioanalytical Solutions Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Clinical
1.3.3 Non-clinical
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Bioanalytical Solutions Revenue Estimates and Forecasts 2020-2031
2.2 Global Bioanalytical Solutions Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Bioanalytical Solutions Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Bioanalytical Solutions Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Small Molecule Bioanalysis Market Size by Players
3.3.2 Large Molecule Bioanalysis Market Size by Players
3.3.3 Biomarkers Market Size by Players
3.3.4 Biologics and Vaccines Market Size by Players
3.4 Global Bioanalytical Solutions Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Bioanalytical Solutions Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Bioanalytical Solutions Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Bioanalytical Solutions Market Size by Type (2020-2031)
6.4 North America Bioanalytical Solutions Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Bioanalytical Solutions Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Bioanalytical Solutions Market Size by Type (2020-2031)
7.4 Europe Bioanalytical Solutions Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Bioanalytical Solutions Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Bioanalytical Solutions Market Size by Type (2020-2031)
8.4 Asia-Pacific Bioanalytical Solutions Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Bioanalytical Solutions Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Bioanalytical Solutions Market Size by Type (2020-2031)
9.4 Central and South America Bioanalytical Solutions Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Bioanalytical Solutions Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Bioanalytical Solutions Market Size by Type (2020-2031)
10.4 Middle East and Africa Bioanalytical Solutions Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Bioanalytical Solutions Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Corporation Information
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific Bioanalytical Solutions Product Features and Attributes
11.1.4 Eurofins Scientific Bioanalytical Solutions Revenue and Gross Margin (2020-2025)
11.1.5 Eurofins Scientific Bioanalytical Solutions Revenue by Product in 2024
11.1.6 Eurofins Scientific Bioanalytical Solutions Revenue by Application in 2024
11.1.7 Eurofins Scientific Bioanalytical Solutions Revenue by Geographic Area in 2024
11.1.8 Eurofins Scientific Bioanalytical Solutions SWOT Analysis
11.1.9 Eurofins Scientific Recent Developments
11.2 Charles River
11.2.1 Charles River Corporation Information
11.2.2 Charles River Business Overview
11.2.3 Charles River Bioanalytical Solutions Product Features and Attributes
11.2.4 Charles River Bioanalytical Solutions Revenue and Gross Margin (2020-2025)
11.2.5 Charles River Bioanalytical Solutions Revenue by Product in 2024
11.2.6 Charles River Bioanalytical Solutions Revenue by Application in 2024
11.2.7 Charles River Bioanalytical Solutions Revenue by Geographic Area in 2024
11.2.8 Charles River Bioanalytical Solutions SWOT Analysis
11.2.9 Charles River Recent Developments
11.3 LabCorp
11.3.1 LabCorp Corporation Information
11.3.2 LabCorp Business Overview
11.3.3 LabCorp Bioanalytical Solutions Product Features and Attributes
11.3.4 LabCorp Bioanalytical Solutions Revenue and Gross Margin (2020-2025)
11.3.5 LabCorp Bioanalytical Solutions Revenue by Product in 2024
11.3.6 LabCorp Bioanalytical Solutions Revenue by Application in 2024
11.3.7 LabCorp Bioanalytical Solutions Revenue by Geographic Area in 2024
11.3.8 LabCorp Bioanalytical Solutions SWOT Analysis
11.3.9 LabCorp Recent Developments
11.4 Altasciences
11.4.1 Altasciences Corporation Information
11.4.2 Altasciences Business Overview
11.4.3 Altasciences Bioanalytical Solutions Product Features and Attributes
11.4.4 Altasciences Bioanalytical Solutions Revenue and Gross Margin (2020-2025)
11.4.5 Altasciences Bioanalytical Solutions Revenue by Product in 2024
11.4.6 Altasciences Bioanalytical Solutions Revenue by Application in 2024
11.4.7 Altasciences Bioanalytical Solutions Revenue by Geographic Area in 2024
11.4.8 Altasciences Bioanalytical Solutions SWOT Analysis
11.4.9 Altasciences Recent Developments
11.5 Intertek
11.5.1 Intertek Corporation Information
11.5.2 Intertek Business Overview
11.5.3 Intertek Bioanalytical Solutions Product Features and Attributes
11.5.4 Intertek Bioanalytical Solutions Revenue and Gross Margin (2020-2025)
11.5.5 Intertek Bioanalytical Solutions Revenue by Product in 2024
11.5.6 Intertek Bioanalytical Solutions Revenue by Application in 2024
11.5.7 Intertek Bioanalytical Solutions Revenue by Geographic Area in 2024
11.5.8 Intertek Bioanalytical Solutions SWOT Analysis
11.5.9 Intertek Recent Developments
11.6 Celerion
11.6.1 Celerion Corporation Information
11.6.2 Celerion Business Overview
11.6.3 Celerion Bioanalytical Solutions Product Features and Attributes
11.6.4 Celerion Bioanalytical Solutions Revenue and Gross Margin (2020-2025)
11.6.5 Celerion Recent Developments
11.7 ACM Global Laboratories
11.7.1 ACM Global Laboratories Corporation Information
11.7.2 ACM Global Laboratories Business Overview
11.7.3 ACM Global Laboratories Bioanalytical Solutions Product Features and Attributes
11.7.4 ACM Global Laboratories Bioanalytical Solutions Revenue and Gross Margin (2020-2025)
11.7.5 ACM Global Laboratories Recent Developments
11.8 Q2 Solutions
11.8.1 Q2 Solutions Corporation Information
11.8.2 Q2 Solutions Business Overview
11.8.3 Q2 Solutions Bioanalytical Solutions Product Features and Attributes
11.8.4 Q2 Solutions Bioanalytical Solutions Revenue and Gross Margin (2020-2025)
11.8.5 Q2 Solutions Recent Developments
11.9 WuXi AppTec
11.9.1 WuXi AppTec Corporation Information
11.9.2 WuXi AppTec Business Overview
11.9.3 WuXi AppTec Bioanalytical Solutions Product Features and Attributes
11.9.4 WuXi AppTec Bioanalytical Solutions Revenue and Gross Margin (2020-2025)
11.9.5 WuXi AppTec Recent Developments
11.10 SGS
11.10.1 SGS Corporation Information
11.10.2 SGS Business Overview
11.10.3 SGS Bioanalytical Solutions Product Features and Attributes
11.10.4 SGS Bioanalytical Solutions Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Ardena
11.11.1 Ardena Corporation Information
11.11.2 Ardena Business Overview
11.11.3 Ardena Bioanalytical Solutions Product Features and Attributes
11.11.4 Ardena Bioanalytical Solutions Revenue and Gross Margin (2020-2025)
11.11.5 Ardena Recent Developments
11.12 VTT
11.12.1 VTT Corporation Information
11.12.2 VTT Business Overview
11.12.3 VTT Bioanalytical Solutions Product Features and Attributes
11.12.4 VTT Bioanalytical Solutions Revenue and Gross Margin (2020-2025)
11.12.5 VTT Recent Developments
11.13 ICON
11.13.1 ICON Corporation Information
11.13.2 ICON Business Overview
11.13.3 ICON Bioanalytical Solutions Product Features and Attributes
11.13.4 ICON Bioanalytical Solutions Revenue and Gross Margin (2020-2025)
11.13.5 ICON Recent Developments
11.14 Simbec-Orion
11.14.1 Simbec-Orion Corporation Information
11.14.2 Simbec-Orion Business Overview
11.14.3 Simbec-Orion Bioanalytical Solutions Product Features and Attributes
11.14.4 Simbec-Orion Bioanalytical Solutions Revenue and Gross Margin (2020-2025)
11.14.5 Simbec-Orion Recent Developments
11.15 Medpace
11.15.1 Medpace Corporation Information
11.15.2 Medpace Business Overview
11.15.3 Medpace Bioanalytical Solutions Product Features and Attributes
11.15.4 Medpace Bioanalytical Solutions Revenue and Gross Margin (2020-2025)
11.15.5 Medpace Recent Developments
11.16 Frontage
11.16.1 Frontage Corporation Information
11.16.2 Frontage Business Overview
11.16.3 Frontage Bioanalytical Solutions Product Features and Attributes
11.16.4 Frontage Bioanalytical Solutions Revenue and Gross Margin (2020-2025)
11.16.5 Frontage Recent Developments
11.17 Pharmaron
11.17.1 Pharmaron Corporation Information
11.17.2 Pharmaron Business Overview
11.17.3 Pharmaron Bioanalytical Solutions Product Features and Attributes
11.17.4 Pharmaron Bioanalytical Solutions Revenue and Gross Margin (2020-2025)
11.17.5 Pharmaron Recent Developments
11.18 Veeda
11.18.1 Veeda Corporation Information
11.18.2 Veeda Business Overview
11.18.3 Veeda Bioanalytical Solutions Product Features and Attributes
11.18.4 Veeda Bioanalytical Solutions Revenue and Gross Margin (2020-2025)
11.18.5 Veeda Recent Developments
11.19 GenScript
11.19.1 GenScript Corporation Information
11.19.2 GenScript Business Overview
11.19.3 GenScript Bioanalytical Solutions Product Features and Attributes
11.19.4 GenScript Bioanalytical Solutions Revenue and Gross Margin (2020-2025)
11.19.5 GenScript Recent Developments
11.20 Sino Biological
11.20.1 Sino Biological Corporation Information
11.20.2 Sino Biological Business Overview
11.20.3 Sino Biological Bioanalytical Solutions Product Features and Attributes
11.20.4 Sino Biological Bioanalytical Solutions Revenue and Gross Margin (2020-2025)
11.20.5 Sino Biological Recent Developments
11.21 Tigermed
11.21.1 Tigermed Corporation Information
11.21.2 Tigermed Business Overview
11.21.3 Tigermed Bioanalytical Solutions Product Features and Attributes
11.21.4 Tigermed Bioanalytical Solutions Revenue and Gross Margin (2020-2025)
11.21.5 Tigermed Recent Developments
11.22 Medicilon
11.22.1 Medicilon Corporation Information
11.22.2 Medicilon Business Overview
11.22.3 Medicilon Bioanalytical Solutions Product Features and Attributes
11.22.4 Medicilon Bioanalytical Solutions Revenue and Gross Margin (2020-2025)
11.22.5 Medicilon Recent Developments
11.23 Scinovo
11.23.1 Scinovo Corporation Information
11.23.2 Scinovo Business Overview
11.23.3 Scinovo Bioanalytical Solutions Product Features and Attributes
11.23.4 Scinovo Bioanalytical Solutions Revenue and Gross Margin (2020-2025)
11.23.5 Scinovo Recent Developments
12 Bioanalytical SolutionsIndustry Chain Analysis
12.1 Bioanalytical Solutions Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Bioanalytical Solutions Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Bioanalytical Solutions Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global Bioanalytical Solutions Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Bioanalytical Solutions Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Bioanalytical Solutions Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Bioanalytical Solutions Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Bioanalytical Solutions Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Bioanalytical Solutions Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Bioanalytical Solutions Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Bioanalytical Solutions by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioanalytical Solutions as of 2024)
 Table 11. Global Bioanalytical Solutions Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Bioanalytical Solutions Companies Headquarters
 Table 13. Global Bioanalytical Solutions Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Bioanalytical Solutions Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Bioanalytical Solutions Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Bioanalytical Solutions Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Bioanalytical Solutions Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Bioanalytical Solutions High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Bioanalytical Solutions Growth Accelerators and Market Barriers
 Table 25. North America Bioanalytical Solutions Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Bioanalytical Solutions Growth Accelerators and Market Barriers
 Table 27. Europe Bioanalytical Solutions Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Bioanalytical Solutions Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Bioanalytical Solutions Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Bioanalytical Solutions Investment Opportunities and Key Challenges
 Table 31. Central and South America Bioanalytical Solutions Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Bioanalytical Solutions Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Bioanalytical Solutions Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Eurofins Scientific Corporation Information
 Table 35. Eurofins Scientific Description and Major Businesses
 Table 36. Eurofins Scientific Product Features and Attributes
 Table 37. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Eurofins Scientific Revenue Proportion by Product in 2024
 Table 39. Eurofins Scientific Revenue Proportion by Application in 2024
 Table 40. Eurofins Scientific Revenue Proportion by Geographic Area in 2024
 Table 41. Eurofins Scientific Bioanalytical Solutions SWOT Analysis
 Table 42. Eurofins Scientific Recent Developments
 Table 43. Charles River Corporation Information
 Table 44. Charles River Description and Major Businesses
 Table 45. Charles River Product Features and Attributes
 Table 46. Charles River Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Charles River Revenue Proportion by Product in 2024
 Table 48. Charles River Revenue Proportion by Application in 2024
 Table 49. Charles River Revenue Proportion by Geographic Area in 2024
 Table 50. Charles River Bioanalytical Solutions SWOT Analysis
 Table 51. Charles River Recent Developments
 Table 52. LabCorp Corporation Information
 Table 53. LabCorp Description and Major Businesses
 Table 54. LabCorp Product Features and Attributes
 Table 55. LabCorp Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. LabCorp Revenue Proportion by Product in 2024
 Table 57. LabCorp Revenue Proportion by Application in 2024
 Table 58. LabCorp Revenue Proportion by Geographic Area in 2024
 Table 59. LabCorp Bioanalytical Solutions SWOT Analysis
 Table 60. LabCorp Recent Developments
 Table 61. Altasciences Corporation Information
 Table 62. Altasciences Description and Major Businesses
 Table 63. Altasciences Product Features and Attributes
 Table 64. Altasciences Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Altasciences Revenue Proportion by Product in 2024
 Table 66. Altasciences Revenue Proportion by Application in 2024
 Table 67. Altasciences Revenue Proportion by Geographic Area in 2024
 Table 68. Altasciences Bioanalytical Solutions SWOT Analysis
 Table 69. Altasciences Recent Developments
 Table 70. Intertek Corporation Information
 Table 71. Intertek Description and Major Businesses
 Table 72. Intertek Product Features and Attributes
 Table 73. Intertek Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Intertek Revenue Proportion by Product in 2024
 Table 75. Intertek Revenue Proportion by Application in 2024
 Table 76. Intertek Revenue Proportion by Geographic Area in 2024
 Table 77. Intertek Bioanalytical Solutions SWOT Analysis
 Table 78. Intertek Recent Developments
 Table 79. Celerion Corporation Information
 Table 80. Celerion Description and Major Businesses
 Table 81. Celerion Product Features and Attributes
 Table 82. Celerion Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Celerion Recent Developments
 Table 84. ACM Global Laboratories Corporation Information
 Table 85. ACM Global Laboratories Description and Major Businesses
 Table 86. ACM Global Laboratories Product Features and Attributes
 Table 87. ACM Global Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. ACM Global Laboratories Recent Developments
 Table 89. Q2 Solutions Corporation Information
 Table 90. Q2 Solutions Description and Major Businesses
 Table 91. Q2 Solutions Product Features and Attributes
 Table 92. Q2 Solutions Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Q2 Solutions Recent Developments
 Table 94. WuXi AppTec Corporation Information
 Table 95. WuXi AppTec Description and Major Businesses
 Table 96. WuXi AppTec Product Features and Attributes
 Table 97. WuXi AppTec Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. WuXi AppTec Recent Developments
 Table 99. SGS Corporation Information
 Table 100. SGS Description and Major Businesses
 Table 101. SGS Product Features and Attributes
 Table 102. SGS Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. SGS Recent Developments
 Table 104. Ardena Corporation Information
 Table 105. Ardena Description and Major Businesses
 Table 106. Ardena Product Features and Attributes
 Table 107. Ardena Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Ardena Recent Developments
 Table 109. VTT Corporation Information
 Table 110. VTT Description and Major Businesses
 Table 111. VTT Product Features and Attributes
 Table 112. VTT Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. VTT Recent Developments
 Table 114. ICON Corporation Information
 Table 115. ICON Description and Major Businesses
 Table 116. ICON Product Features and Attributes
 Table 117. ICON Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. ICON Recent Developments
 Table 119. Simbec-Orion Corporation Information
 Table 120. Simbec-Orion Description and Major Businesses
 Table 121. Simbec-Orion Product Features and Attributes
 Table 122. Simbec-Orion Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Simbec-Orion Recent Developments
 Table 124. Medpace Corporation Information
 Table 125. Medpace Description and Major Businesses
 Table 126. Medpace Product Features and Attributes
 Table 127. Medpace Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. Medpace Recent Developments
 Table 129. Frontage Corporation Information
 Table 130. Frontage Description and Major Businesses
 Table 131. Frontage Product Features and Attributes
 Table 132. Frontage Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. Frontage Recent Developments
 Table 134. Pharmaron Corporation Information
 Table 135. Pharmaron Description and Major Businesses
 Table 136. Pharmaron Product Features and Attributes
 Table 137. Pharmaron Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. Pharmaron Recent Developments
 Table 139. Veeda Corporation Information
 Table 140. Veeda Description and Major Businesses
 Table 141. Veeda Product Features and Attributes
 Table 142. Veeda Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. Veeda Recent Developments
 Table 144. GenScript Corporation Information
 Table 145. GenScript Description and Major Businesses
 Table 146. GenScript Product Features and Attributes
 Table 147. GenScript Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 148. GenScript Recent Developments
 Table 149. Sino Biological Corporation Information
 Table 150. Sino Biological Description and Major Businesses
 Table 151. Sino Biological Product Features and Attributes
 Table 152. Sino Biological Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 153. Sino Biological Recent Developments
 Table 154. Tigermed Corporation Information
 Table 155. Tigermed Description and Major Businesses
 Table 156. Tigermed Product Features and Attributes
 Table 157. Tigermed Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 158. Tigermed Recent Developments
 Table 159. Medicilon Corporation Information
 Table 160. Medicilon Description and Major Businesses
 Table 161. Medicilon Product Features and Attributes
 Table 162. Medicilon Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 163. Medicilon Recent Developments
 Table 164. Scinovo Corporation Information
 Table 165. Scinovo Description and Major Businesses
 Table 166. Scinovo Product Features and Attributes
 Table 167. Scinovo Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 168. Scinovo Recent Developments
 Table 169. Raw Materials Key Suppliers
 Table 170. Distributors List
 Table 171. Market Trends and Market Evolution
 Table 172. Market Drivers and Opportunities
 Table 173. Market Challenges, Risks, and Restraints
 Table 174. Research Programs/Design for This Report
 Table 175. Key Data Information from Secondary Sources
 Table 176. Key Data Information from Primary Sources


List of Figures
 Figure 1. Bioanalytical Solutions Product Picture
 Figure 2. Global Bioanalytical Solutions Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Small Molecule Bioanalysis Product Picture
 Figure 4. Large Molecule Bioanalysis Product Picture
 Figure 5. Biomarkers Product Picture
 Figure 6. Biologics and Vaccines Product Picture
 Figure 7. Global Bioanalytical Solutions Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Clinical
 Figure 9. Non-clinical
 Figure 10. Bioanalytical Solutions Report Years Considered
 Figure 11. Global Bioanalytical Solutions Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Bioanalytical Solutions Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Bioanalytical Solutions Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Bioanalytical Solutions Revenue Market Share by Region (2020-2031)
 Figure 15. Global Bioanalytical Solutions Revenue Market Share Ranking (2024)
 Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 17. Small Molecule Bioanalysis Revenue Market Share by Player in 2024
 Figure 18. Large Molecule Bioanalysis Revenue Market Share by Player in 2024
 Figure 19. Biomarkers Revenue Market Share by Player in 2024
 Figure 20. Biologics and Vaccines Revenue Market Share by Player in 2024
 Figure 21. Global Bioanalytical Solutions Revenue Market Share by Type (2020-2031)
 Figure 22. Global Bioanalytical Solutions Revenue Market Share by Application (2020-2031)
 Figure 23. North America Bioanalytical Solutions Revenue YoY (2020-2031) & (US$ Million)
 Figure 24. North America Top 5 Players Bioanalytical Solutions Revenue (US$ Million) in 2024
 Figure 25. North America Bioanalytical Solutions Revenue (US$ Million) by Type (2020 - 2031)
 Figure 26. North America Bioanalytical Solutions Revenue (US$ Million) by Application (2020-2031)
 Figure 27. US Bioanalytical Solutions Revenue (2020-2031) & (US$ Million)
 Figure 28. Canada Bioanalytical Solutions Revenue (2020-2031) & (US$ Million)
 Figure 29. Mexico Bioanalytical Solutions Revenue (2020-2031) & (US$ Million)
 Figure 30. Europe Bioanalytical Solutions Revenue YoY (2020-2031) & (US$ Million)
 Figure 31. Europe Top 5 Players Bioanalytical Solutions Revenue (US$ Million) in 2024
 Figure 32. Europe Bioanalytical Solutions Revenue (US$ Million) by Type (2020-2031)
 Figure 33. Europe Bioanalytical Solutions Revenue (US$ Million) by Application (2020-2031)
 Figure 34. Germany Bioanalytical Solutions Revenue (2020-2031) & (US$ Million)
 Figure 35. France Bioanalytical Solutions Revenue (2020-2031) & (US$ Million)
 Figure 36. U.K. Bioanalytical Solutions Revenue (2020-2031) & (US$ Million)
 Figure 37. Italy Bioanalytical Solutions Revenue (2020-2031) & (US$ Million)
 Figure 38. Russia Bioanalytical Solutions Revenue (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Bioanalytical Solutions Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Asia-Pacific Top 8 Players Bioanalytical Solutions Revenue (US$ Million) in 2024
 Figure 41. Asia-Pacific Bioanalytical Solutions Revenue (US$ Million) by Type (2020-2031)
 Figure 42. Asia-Pacific Bioanalytical Solutions Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Indonesia Bioanalytical Solutions Revenue (2020-2031) & (US$ Million)
 Figure 44. Japan Bioanalytical Solutions Revenue (2020-2031) & (US$ Million)
 Figure 45. South Korea Bioanalytical Solutions Revenue (2020-2031) & (US$ Million)
 Figure 46. Australia Bioanalytical Solutions Revenue (2020-2031) & (US$ Million)
 Figure 47. India Bioanalytical Solutions Revenue (2020-2031) & (US$ Million)
 Figure 48. Indonesia Bioanalytical Solutions Revenue (2020-2031) & (US$ Million)
 Figure 49. Vietnam Bioanalytical Solutions Revenue (2020-2031) & (US$ Million)
 Figure 50. Malaysia Bioanalytical Solutions Revenue (2020-2031) & (US$ Million)
 Figure 51. Philippines Bioanalytical Solutions Revenue (2020-2031) & (US$ Million)
 Figure 52. Singapore Bioanalytical Solutions Revenue (2020-2031) & (US$ Million)
 Figure 53. Central and South America Bioanalytical Solutions Revenue YoY (2020-2031) & (US$ Million)
 Figure 54. Central and South America Top 5 Players Bioanalytical Solutions Revenue (US$ Million) in 2024
 Figure 55. Central and South America Bioanalytical Solutions Revenue (US$ Million) by Type (2020-2031)
 Figure 56. Central and South America Bioanalytical Solutions Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Brazil Bioanalytical Solutions Revenue (2020-2025) & (US$ Million)
 Figure 58. Argentina Bioanalytical Solutions Revenue (2020-2025) & (US$ Million)
 Figure 59. Middle East and Africa Bioanalytical Solutions Revenue YoY (2020-2031) & (US$ Million)
 Figure 60. Middle East and Africa Top 5 Players Bioanalytical Solutions Revenue (US$ Million) in 2024
 Figure 61. South America Bioanalytical Solutions Revenue (US$ Million) by Type (2020-2031)
 Figure 62. Middle East and Africa Bioanalytical Solutions Revenue (US$ Million) by Application (2020-2031)
 Figure 63. GCC Countries Bioanalytical Solutions Revenue (2020-2025) & (US$ Million)
 Figure 64. Israel Bioanalytical Solutions Revenue (2020-2025) & (US$ Million)
 Figure 65. Egypt Bioanalytical Solutions Revenue (2020-2025) & (US$ Million)
 Figure 66. South Africa Bioanalytical Solutions Revenue (2020-2025) & (US$ Million)
 Figure 67. Bioanalytical Solutions Industry Chain Mapping
 Figure 68. Channels of Distribution (Direct Vs Distribution)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart